Human CD4+ T cell enrichment is often used to create a defined T-cell population for downstream immune-cell workflows. Magnetic positive selection offers a direct way to capture the marker-positive population, but the separation reagent still needs to fit the next experimental step—not just the enrichment step itself.
MileCell MagSep™ CD4 MicroBeads, Human (Cat. No. AB0001) are listed within the MagSep™ positive-selection portfolio for human CD4+ T cells. The platform uses superparamagnetic nanoparticles with surface-conjugated monoclonal antibodies and is designed around nanoscale labeling, downstream compatibility, and consistent reagent quality.
Product at a glance
Product: CD4 MicroBeads, Human
Target cell: Human CD4+ T cells
Selection strategy: Positive selection
Cat. No. : AB0001
MagSep™ platform particle size: 100 nm
CD4 MicroBeads are magnetic separation reagents designed to enrich CD4-expressing T cells by direct target-cell labeling. In the MagSep™ platform, superparamagnetic nanoparticles bind target cells through surface-conjugated monoclonal antibodies. Once labeled, the target population can be separated in a magnetic field while non-target cells are removed from the selected fraction.
This direct-capture approach is the defining feature of positive selection. It is especially useful when the workflow calls for a clearly marker-defined CD4+ T cell population and the laboratory wants a straightforward magnetic enrichment step without a flow sorter.
The MagSep™ workflow is built around magnetic enrichment. The target population is identified through antibody specificity, exposed to the magnetic separation step, and collected as the selected fraction. The same platform also includes negative-selection kits for workflows that prioritize an untouched target population, so the strategy can be chosen around the needs of the downstream assay.
Figure 1. Example MileCell MagSep™ magnetic cell-separation workflow. Positive selection uses MicroBeads to directly capture the target population; negative selection removes non-target cells.
CD4 MicroBeads, Human are specified for human CD4+ T cells. A clean enrichment strategy starts with a clearly defined marker and a downstream plan that matches direct positive selection.
The MagSep™ platform uses 100 nm magnetic nanoparticles. The product platform emphasizes minimal labeling, with the aim of maximizing cell viability and avoiding functional interference during separation.
The MagSep™ materials are described as biodegradable and low-endotoxin, with compatibility for flow cytometry, in vitro culture, and single-cell sequencing. This makes downstream workflow fit an important part of reagent selection rather than an afterthought.
A residue-free separation platform can simplify the transition from magnetic enrichment into downstream analysis or culture. MagSep™ is positioned around high compatibility and residue-free performance.
Cell isolation is often repeated across donors, operators, or experimental runs. The MagSep™ platform emphasizes exceptional batch-to-batch consistency and stable product quality to support reproducible experimental outcomes.
The MagSep™ portfolio is presented under ISO 9001, ISO 14001, and ISO 45001 systems. For laboratories standardizing immune-cell workflows, reagent manufacturing and quality-system consistency are part of overall method control.
Positive selection directly labels the target cells. If a workflow instead requires an untouched target population, a negative-selection strategy may be more appropriate. The practical choice should be made from the needs of the next assay backward.
Figure 2. MagSep™ platform attributes highlighted for immune-cell separation: expert-driven design, nanoscale precision, high compatibility with residue-free performance, and batch-to-batch consistency.
Before starting a CD4+ T cell enrichment workflow, it helps to define the experiment in terms of the target, the desired handling state of the cells, and the downstream application. The checklist below keeps the decision anchored to the product attributes available for the MagSep™ platform.
| Evaluation Area | Questions to Confirm |
| Target | Is the intended population human CD4+ T cells? |
| Selection strategy | Is direct positive selection appropriate for the downstream assay? |
| Particle design | Does the workflow benefit from 100 nm nanomagnetic particles with minimal labeling? |
| Compatibility | Will the enriched cells move into flow cytometry, in vitro culture, or single-cell sequencing? |
| Material profile | Is a biodegradable, low-endotoxin, residue-free platform preferred? |
| Consistency | Is stable lot-to-lot reagent quality important for repeated studies? |
Within the current MagSep™ product range, CD4 MicroBeads, Human are the positive-selection reagent for human CD4+ T cells. The listed catalog number is AB0001. The broader platform is based on superparamagnetic nanoparticles, target-cell binding through surface-conjugated monoclonal antibodies, nanoscale precision, and compatibility with common downstream immune-cell workflows.
Figure 3. MileCell MagSep™ immune-cell separation product portfolio showing CD4 MicroBeads, Human (Cat. No. AB0001) in the positive-selection range.
Positive and negative magnetic selection differ mainly in which cells are labeled. Positive selection labels and captures the target cells directly. Negative selection labels and removes non-target cells so that the desired population remains unlabeled. For CD4+ T cell enrichment with the listed MagSep™ CD4 MicroBeads, the workflow is positive selection.
| Decision Point | Positive Selection | Negative Selection |
| Cells labeled | Target cells | Non-target cells |
| Target output | Marker-defined selected fraction | Untouched target fraction |
| Best fit | Direct enrichment of a defined marker-positive population | Workflows where target-cell labeling is undesirable |
| MileCell CD4 option | CD4 MicroBeads, Human (AB0001) | No CD4-specific negative-selection kit is listed in the supplied product portfolio |
Evidence note: The current product dataset specifies the CD4 target, catalog number, bead platform attributes, workflow compatibility, and quality systems.
No CD4-specific purity, recovery, or yield value is stated here. Accordingly, this article does not assign a numerical CD4 enrichment performance value.
They are a positive-selection reagent for enriching human CD4+ T cells through magnetic separation.
The listed catalog number is AB0001.
The MagSep™ platform specifies 100 nm magnetic nanoparticles with minimal labeling.
The platform is described as compatible with flow cytometry, in vitro culture, and single-cell sequencing.
The materials are described as biodegradable, low-endotoxin, and residue-free.
The portfolio is presented with ISO 9001, ISO 14001, and ISO 45001 systems.
CD4+ T cell enrichment is most reliable when the separation strategy is chosen around both the target marker and the next experimental step. MileCell MagSep™ CD4 MicroBeads, Human (AB0001) provide a positive-selection option for human CD4+ T cells within a 100 nm nanomagnetic platform designed around minimal labeling, downstream compatibility, residue-free performance, and consistent reagent quality.
For laboratories building or standardizing a human T-cell enrichment workflow, the next step is to align the selection strategy with the intended assay and validate performance under the laboratory’s own sample and process conditions.
Ready to plan your CD4+ T cell enrichment workflow?
Explore MileCell MagSep™ CD4 MicroBeads, Human (Cat. No. AB0001).
Contact the MileCell team for product information, technical support, or a datasheet.
Info@milecell-bio.com | www.milecell-bio.com